CD8A and neoplasm: In vivo, GOP@aPD1 NPs were intravenously injected into B16F10 melanoma-bearing mice, which achieved the synergistic antitumor efficacy mediated with PTT duo to the efficient delivery of anti-PD1 and increased CD8+ T cells accumulation in tumor sites.